Gene Therapies For Spinal Cord-Related Disorders With SwanBio's CSO
Source: Cell & Gene
![21_06_CGPodcast_1200x628_Ep6.2 21_06_CGPodcast_1200x628_Ep6.2](https://vertassets.blob.core.windows.net/image/b917a954/b917a954-e8aa-472f-b18f-9019304f0e9c/375_250-21_06_cgpodcast_1200x628_ep6_2.png)
Karen Kozarsky, Ph.D., Co-Founder and CSO of SwanBio explains how the company is pioneering a deep and varied pipeline of gene therapies for genetically defined neurological diseases with a focus on the spinal cord.
This website uses cookies to ensure you get the best experience on our website. Learn more